Blavatnik Family Foundation donation to the Harvard Medical School


Scientific Research and Discovery

Through the Blavatnik Family Foundation, Len has established and supports various programs that enable young scientists and research institutions worldwide to discover new solutions that have the potential to transform society 

Harvard University

As a Harvard Business School alumni, Len, through the Foundation, has made a series of significant donations that have dramatically advanced the research capabilities of the University and its researchers in the last ten years.  

In November 2018, the Foundation gifted $200 million to Harvard Medical School to support initiatives aimed at solving some of humanity’s most acute biomedical challenges. The gift, the largest in the School’s 236-year history, helps stimulate the development of new tools to diagnose and prevent disease. 

“This transformational gift will bring us closer to solving the most intractable health challenges of our time.” 

– George Q. Daley, Dean of Harvard Medical School  

In 2013, the Foundation donated $50 million to the University to launch a major initiative to promote the nexus between scientific innovation and business. The funding helped to create the Blavatnik Biomedical Accelerator and the Blavatnik Fellowship in Life Science Entrepreneurship program. The former aims to bridge the gap between innovative, early-stage life science research and successful development of high-impact biomedical products, while the latter offers Harvard Business School alumni the opportunity to create new ventures around promising life-science technologies while developing their leadership talents. 

In 2009, the Foundation provided $10 million of support to the University for scientific and technological research in life sciences. This donation comprised $5 million of support to the Eli and Edythe L. Broad Institute of Harvard and Massachusetts Institute of Technology for cancer vaccine research, and $5 million to the Harvard University Technology Development Accelerator Fund. 

Yale University

Len has been a consistent supporter of Yale University’s science research, with donations made through the Foundation totalling $45 million.  

The funding helped set up the Blavatnik Fund for Innovation at Yale and the Blavatnik Fellows Program, among other initiatives 

The Blavatnik Fund for Innovation at Yale is designed to bridge the gap between life sciences research and business, and to accelerate the commercialization of ground-breaking discoveries. 

Whereas, the Fellows Program aims to connect a select group of young professionals with leading academic peers and researchers to provide them with the technical skills needed to become the next generation of entrepreneurial leaders. 

Tel Aviv University

The Blavatnik Initative, funded by the Foundation, was launched at Tel Aviv University (TAU) in 2014. This is a multi-year program aimed at advancing the University’s level of interdisciplinary research and development.   

As part of this Initiative, the Blavatnik Center for Drug Discovery was established with the aim of combining biological, chemical and computational research to develop new medications that will alleviate suffering and save lives. 

Len also helped set up the Blavatnik President’s Faculty Recruitment Discretionary Fund to bolster the University’s acquisition of outstanding young Israeli scientists. The support is aimed at those researching innovative areas including nanoscience, neuroscience, environmental studies, computational linguistics and tissue engineering 

The total TAU has received more than $40 million from Len’s contributions. 

Other scientific support

The Foundation has also supported the following scientific and research institutes: 

  • Stanford University 
  • Columbia University 
  • Mount Sinai Medical Center 
  • University of Pennsylvania 
  • University of Cambridge
  • Sabin Vaccine Institute 
  • Ational Academy of Sciences 
  • Israel Academy of Sciences And Humanities 

Click here to find out more about Len’s contributions to scientific and medical research